GR3033509T3 - N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them - Google Patents
N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- GR3033509T3 GR3033509T3 GR20000401200T GR20000401200T GR3033509T3 GR 3033509 T3 GR3033509 T3 GR 3033509T3 GR 20000401200 T GR20000401200 T GR 20000401200T GR 20000401200 T GR20000401200 T GR 20000401200T GR 3033509 T3 GR3033509 T3 GR 3033509T3
- Authority
- GR
- Greece
- Prior art keywords
- halo
- saturated
- optionally substituted
- unsaturated
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611501A FR2753706B1 (fr) | 1996-09-20 | 1996-09-20 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3033509T3 true GR3033509T3 (en) | 2000-09-29 |
Family
ID=9495928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000401200T GR3033509T3 (en) | 1996-09-20 | 2000-05-25 | N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5919801A (el) |
| EP (1) | EP0831090B1 (el) |
| JP (1) | JPH10101645A (el) |
| AT (1) | ATE191717T1 (el) |
| AU (1) | AU718489B2 (el) |
| BR (1) | BR9704757A (el) |
| CA (1) | CA2216664C (el) |
| DE (1) | DE69701662T2 (el) |
| DK (1) | DK0831090T3 (el) |
| ES (1) | ES2147427T3 (el) |
| FR (1) | FR2753706B1 (el) |
| GR (1) | GR3033509T3 (el) |
| HU (1) | HU221811B1 (el) |
| NO (1) | NO313997B1 (el) |
| NZ (1) | NZ328789A (el) |
| PL (1) | PL322192A1 (el) |
| PT (1) | PT831090E (el) |
| ZA (1) | ZA978462B (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6867209B1 (en) | 1998-05-22 | 2005-03-15 | Scios, Inc. | Indole-type derivatives as inhibitors of p38 kinase |
| US6130235A (en) * | 1998-05-22 | 2000-10-10 | Scios Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6589954B1 (en) | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6448257B1 (en) | 1998-05-22 | 2002-09-10 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| AU769465B2 (en) * | 1998-05-22 | 2004-01-29 | Scios Inc. | Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| US6340685B1 (en) | 1998-05-22 | 2002-01-22 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| DZ2876A1 (fr) | 1998-08-26 | 2003-12-15 | Smithkline Beecham Corp | Composition comprenant un inhibiteur de pde4 et unbroncho-dilatateur beta-andrenergique, et procédé pour leur préparation. |
| IL146309A (en) | 1999-05-21 | 2008-03-20 | Scios Inc | Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38 |
| KR100515905B1 (ko) * | 2000-01-31 | 2005-09-21 | 주식회사 엘지생명과학 | 피롤아미드의 새로운 제조방법 |
| HUP0300689A3 (en) * | 2000-02-08 | 2003-09-29 | Smithkline Beecham Corp | Method and compositions for treating an inflammatory disease |
| US20030207845A1 (en) * | 2001-02-08 | 2003-11-06 | Keating Elizabeth T. | Method and compositions for treating an inflammatory disease |
| DE10035928A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| CA2418313C (en) * | 2000-08-11 | 2008-09-23 | Ono Pharmaceutical Co., Ltd. | Piperidine derivatives and agent comprising the derivative as active ingredient |
| US20040219552A1 (en) * | 2001-08-14 | 2004-11-04 | Ali Ait Ikhlef | Novel molecular target for neurotoxicity |
| FR2856595B1 (fr) * | 2003-06-27 | 2008-05-30 | Exonhit Therapeutics Sa | Methodes et compositions pour le traitement de deficits cognitifs. |
| KR20100098653A (ko) * | 2007-11-21 | 2010-09-08 | 디코드 제네틱스 이에이치에프 | 염증의 치료를 위한 바이아릴 ｐｄｅ４ 억제제 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6850M (el) * | 1967-12-05 | 1969-04-08 | ||
| US5459151A (en) * | 1993-04-30 | 1995-10-17 | American Home Products Corporation | N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents |
| US5434158A (en) * | 1994-04-26 | 1995-07-18 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin-3 antagonists |
| US5530012A (en) * | 1994-12-22 | 1996-06-25 | Bristol-Myers Squibb Co. | 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| US5703239A (en) * | 1995-06-02 | 1997-12-30 | Bristol-Myers Squibb Company | Indanylpiperidines as melatonergic agents |
-
1996
- 1996-09-20 FR FR9611501A patent/FR2753706B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-12 JP JP9248357A patent/JPH10101645A/ja active Pending
- 1997-09-15 NO NO19974253A patent/NO313997B1/no unknown
- 1997-09-19 DE DE69701662T patent/DE69701662T2/de not_active Expired - Fee Related
- 1997-09-19 CA CA002216664A patent/CA2216664C/fr not_active Expired - Fee Related
- 1997-09-19 BR BR9704757A patent/BR9704757A/pt unknown
- 1997-09-19 HU HU9701561A patent/HU221811B1/hu not_active IP Right Cessation
- 1997-09-19 AT AT97402175T patent/ATE191717T1/de not_active IP Right Cessation
- 1997-09-19 NZ NZ328789A patent/NZ328789A/en unknown
- 1997-09-19 PT PT97402175T patent/PT831090E/pt unknown
- 1997-09-19 ZA ZA9708462A patent/ZA978462B/xx unknown
- 1997-09-19 PL PL97322192A patent/PL322192A1/xx unknown
- 1997-09-19 US US08/934,409 patent/US5919801A/en not_active Expired - Fee Related
- 1997-09-19 EP EP97402175A patent/EP0831090B1/fr not_active Expired - Lifetime
- 1997-09-19 DK DK97402175T patent/DK0831090T3/da active
- 1997-09-19 ES ES97402175T patent/ES2147427T3/es not_active Expired - Lifetime
- 1997-09-19 AU AU38362/97A patent/AU718489B2/en not_active Ceased
-
2000
- 2000-05-25 GR GR20000401200T patent/GR3033509T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU9701561D0 (en) | 1997-11-28 |
| NO974253D0 (no) | 1997-09-15 |
| JPH10101645A (ja) | 1998-04-21 |
| DE69701662T2 (de) | 2000-11-23 |
| EP0831090A1 (fr) | 1998-03-25 |
| EP0831090B1 (fr) | 2000-04-12 |
| HUP9701561A3 (en) | 1998-07-28 |
| BR9704757A (pt) | 1998-09-01 |
| NO313997B1 (no) | 2003-01-13 |
| CA2216664C (fr) | 2002-05-21 |
| ATE191717T1 (de) | 2000-04-15 |
| US5919801A (en) | 1999-07-06 |
| ES2147427T3 (es) | 2000-09-01 |
| PL322192A1 (en) | 1998-03-30 |
| NO974253L (no) | 1998-03-23 |
| PT831090E (pt) | 2000-07-31 |
| FR2753706A1 (fr) | 1998-03-27 |
| AU718489B2 (en) | 2000-04-13 |
| CA2216664A1 (fr) | 1998-03-20 |
| HU221811B1 (hu) | 2003-01-28 |
| NZ328789A (en) | 1998-02-26 |
| HUP9701561A2 (hu) | 1998-05-28 |
| DE69701662D1 (de) | 2000-05-18 |
| ZA978462B (en) | 1998-03-24 |
| DK0831090T3 (da) | 2000-09-11 |
| FR2753706B1 (fr) | 1998-10-30 |
| AU3836297A (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3033509T3 (en) | N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them | |
| FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| AR032130A1 (es) | Un compuesto inhibidor de quinasas proteicas, una composicion farmaceutica que lo incluye, y un metodo para tratar afecciones con dicho compuesto | |
| AR065937A2 (es) | Compuesto derivado indazol, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de proteina quinasa | |
| AR005357A1 (es) | Derivados de 14-o-carbamoil mutilina y sus sales utiles en el tratamiento de infecciones bacterianas, procedimiento para prepararlas, composicionesfarmaceuticas formuladas con dichos derivados y uso de los mismos para preparar dichas composiciones | |
| DE60010596D1 (de) | Pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| KR890014098A (ko) | 카테콜 아민 유도체를 함유하여 이루어지는 중추성 신경퇴행성 질환의 진행방지 및 치료제 | |
| DE60002142D1 (de) | 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazol- und 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazol- Derivate, ihr Verfahren zur Herstellung und pharmazeutische Zusammensetzungen, diese enthaltend | |
| AR002715A1 (es) | Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados | |
| PT96757A (pt) | Processo de preparacao de derivados de indolo e de composicoes farmaceuticas | |
| FR2795071B1 (fr) | Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2757859B1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ZA9711708B (en) | Ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |